The Valley Desk

NCT01321541 · Interventional trial

Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant

Overall registry status Completed

Phase 3

Conditions DLBCL Transformed From Indolent Lymphoma, Diffuse Large B-cell Lymphoma, Follicular Grade 3 Lymphoma, de Novo DLBCL

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov